106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
Order additional copies at GuidelineCentral.com
Copyright © 2021 All rights reserved
ACRRA06213
Source
Fraenkel L, Bathon JM, England BR, et al. 2021 American College of Rheumatolog y
Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care Res (Hoboken).
2021 Jun 8. doi: 10.1002/acr.24596. Epub ahead of print. PMID: 34101387.
Abbreviations
ACR, American College of Rheumatolog y; DMARDs, disease modifying anti-rheumatic
drugs [csDMARDs, conventional synthetic DMARDs; bDMARDs, biologic DMARDs;
tsDMARDs, targeted synthetic DMARDs]; FDA, Food and Drug Aministration; HCQ,
hydroxychloroquine; IA, intraarticular; NAFLD, nonalcoholic fatty liver disease; NTM,
Nontuberculous Mycobacterial; RA, rheumatoid arthritis; SSZ, sulfasalazine; TNF,
tumor necrosis factor; TTT, treat to target
Disclaimer
is pocket guide attempts to define principles of practice that should produce high-quality
patient care. It is applicable to specialists, primary care, and providers at all levels. is
pocket guide should not be considered exclusive of other methods of care reasonably directed at
obtaining the same results. e ultimate judgment concerning the propriety of any course of
conduct must be made by the clinician aer consideration of each individual patient situation.
Neither IGC, the American College of Rheumatology, nor the authors endorse any product or
service associated with the distributor of this clinical reference tool.
